Prostate-specific antigen (PSA) screening aims to identify men who may harbor potentially lethal prostate cancer, and those with high PSA results often require more extensive (and expensive) ...

A British-made prostate cancer test could avoid the need for biopsies in four out of five cases, according to a study. The EpiSwitch PSE next generation blood test uses advances in technology to ...

American researchers have developed a urine test showing promise in prostate cancer detection, potentially reducing the need for painful biopsies. The test identifies three biomarkers—TTC3, H4C5, and ...

SOUTH SAN FRANCISCO, Calif., April 25, 2025--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced the launch of its Decipher Prostate Metastatic ...

Prostate cancer is the malignant growth of cells in the prostate, a walnut-sized gland below the bladder, that is responsible for producing semen. The majority of prostate cancers develop at a slow ...

Healthy living, heart disease and stress are typically what dominate discussions related to men's overall health, but prostate cancer is an under-discussed topic that exists behind the scenes of what ...

SOUTH SAN FRANCISCO, Calif. - Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company with a market capitalization of $2.51 billion and impressive revenue growth of 23.46% in the last twelve ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

The Royal Devon & Exeter Hospital is one of the first in the country to offer a day case prostate procedure. The National Institute for Clinical Excellence has announced a procedure called prostate ...

Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate therapy TORONTO, Nov. 18, 2025 ...